Cover Image for Nucleate ✕ idalab | AI in Biotech
Cover Image for Nucleate ✕ idalab | AI in Biotech

Nucleate ✕ idalab | AI in Biotech

Hosted by Nucleate Germany, Julian Beimes & Paul von Bünau
Registration
Past Event
Welcome! To join the event, please register below.
About Event

Join us for an evening exploring the latest developments in AI along the drug development value chain, from early discovery to clinical translation and beyond. This panel brings together perspectives from a global pharmaceutical company, a clinical-stage biotech, and a venture capital investor. We’ll explore how pharma is integrating AI into large-scale R&D pipelines, how biotech companies are leveraging AI to innovate faster, and what investors look for in AI-driven biotech ventures.

Panelists

  • Djork-Arné Clevert, VP & Head of Machine Learning at Pfizer

  • Jonathan Montagu, President & CEO at HotSpot Therapeutics

  • Rabab Nasrallah, Principal at Earlybird Health

Agenda

  • 18:00 - Doors open

  • 18:30 - Panel starts

  • 19:30 - Drinks and networking

Location
idalab GmbH
Potsdamer Str. 68, 10785 Berlin, Germany